BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26606524)

  • 21. Repertoire Analysis of B-Cells Located in Striated Ducts of Salivary Glands of Patients With Sjögren's Syndrome.
    Visser A; Verstappen GM; van der Vegt B; Vissink A; Bende RJ; Bootsma H; Bos NA; Kroese FGM
    Front Immunol; 2020; 11():1486. PubMed ID: 32760405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune complexes in Sjögren's syndrome.
    Fischbach M; Char D; Christensen M; Daniels T; Whaley K; Alspaugh M; Talal N
    Arthritis Rheum; 1980 Jul; 23(7):791-5. PubMed ID: 6902669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.
    Royer B; Cazals-Hatem D; Sibilia J; Agbalika F; Cayuela JM; Soussi T; Maloisel F; Clauvel JP; Brouet JC; Mariette X
    Blood; 1997 Jul; 90(2):766-75. PubMed ID: 9226177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary study of the relationship between tumor like Sjögren's syndrome and malignant lymphoma].
    Lu SH; Yan ZM; Wei MJ; Gao Y; Hua H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Apr; 47(4):208-13. PubMed ID: 22800698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ; Kelder JC
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
    Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
    Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
    Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
    Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
    Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
    J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
    Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
    Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome.
    Fox RI; Chen P; Carson DA; Fong S
    J Immunol; 1986 Jan; 136(2):477-83. PubMed ID: 3079786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
    Mariette X
    Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
    Anquetil C; Hachulla E; Machuron F; Mariette X; Le Guern V; Vittecoq O; Dernis E; Larroche C; Dubost JJ; Perdriger A; Devauchelle-Pensec V; Fauchais AL; Morel J; Dieudé P; Rist S; Sene D; Gottenberg JE; Hatron PY
    Rheumatology (Oxford); 2019 Jul; 58(7):1163-1167. PubMed ID: 30561748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome.
    Risselada AP; Kruize AA; Goldschmeding R; Lafeber FP; Bijlsma JW; van Roon JA
    Ann Rheum Dis; 2014 Aug; 73(8):1537-40. PubMed ID: 24525912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
    Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
    Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.